About the National Data
Baseline: 41.4 percent of adolescents aged 12 to 17 years with MDEs received treatment in the past 12 months, as reported in 2018
Target: 46.4 percent
Percentage point improvement
Effect size h=0.1 was chosen to correspond with 10% improvement from a baseline of 50%.